Virtual Screening: An Alternative or Complement to High Throughput Screening?

Proceedings of the Workshop ‘New Approaches in Drug Design and Discovery’, special topic ‘Virtual Screening’, Schloß Rauischholzhausen, Germany, March 15–18, 1999

Nonfiction, Health & Well Being, Medical, Specialties, Pharmacy, Science & Nature, Science, Chemistry, General Chemistry
Cover of the book Virtual Screening: An Alternative or Complement to High Throughput Screening? by , Springer Netherlands
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9780306468834
Publisher: Springer Netherlands Publication: May 8, 2007
Imprint: Springer Language: English
Author:
ISBN: 9780306468834
Publisher: Springer Netherlands
Publication: May 8, 2007
Imprint: Springer
Language: English

In the next couple of years the human genome will be fully sequenced. This will provide us with the sequence and overall function of all human genes as well as the complete genome for many micro-organisms. Subsequently it is hoped, by means of powerful bioinformatic tools, to determine the gene variants that contribute to various multifactorial diseases and genes that exist in certain infectious agents but not humans. As a consequence, this will allow us to define the most appropriate levels for drug intervention. It can be expected that the number of potential drug targets will increase, possibly by a factor of 10 or more. Nevertheless, sequencing the human genome or, for that matter, the genome of other species will only be the starting point for the understanding of their biological function. Structural genomics is a likely follow-up, combined with new techniques to validate the therapeutic relevance of such newly discovered targets. Accordingly, it can be expected that in the near future we will witness a substantial increase in novel putative targets for drugs. To address these new targets effectively, we require new approaches and innovative tools. At present, two alternative, yet complementary, techniques are employed: experimental high-throughput screening (HTS) of large compound libraries, increasingly provided by combinatorial chemistry, and computational methods for virtual screening and de novo design.
As kind of status report on the maturity of virtual screening as a technique in drug design, the first workshop on new approaches in drug design and discovery was held in March 1999, at Schloß Rauischholzhausen, near Marburg in Germany. More than 80 scientists gathered and discussed their experience with the different techniques. The speakers were invited to summarize their contributions together with their impressions on the present applicability of their approach. Several of the speakers followed this request which is summarized in this publication.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

In the next couple of years the human genome will be fully sequenced. This will provide us with the sequence and overall function of all human genes as well as the complete genome for many micro-organisms. Subsequently it is hoped, by means of powerful bioinformatic tools, to determine the gene variants that contribute to various multifactorial diseases and genes that exist in certain infectious agents but not humans. As a consequence, this will allow us to define the most appropriate levels for drug intervention. It can be expected that the number of potential drug targets will increase, possibly by a factor of 10 or more. Nevertheless, sequencing the human genome or, for that matter, the genome of other species will only be the starting point for the understanding of their biological function. Structural genomics is a likely follow-up, combined with new techniques to validate the therapeutic relevance of such newly discovered targets. Accordingly, it can be expected that in the near future we will witness a substantial increase in novel putative targets for drugs. To address these new targets effectively, we require new approaches and innovative tools. At present, two alternative, yet complementary, techniques are employed: experimental high-throughput screening (HTS) of large compound libraries, increasingly provided by combinatorial chemistry, and computational methods for virtual screening and de novo design.
As kind of status report on the maturity of virtual screening as a technique in drug design, the first workshop on new approaches in drug design and discovery was held in March 1999, at Schloß Rauischholzhausen, near Marburg in Germany. More than 80 scientists gathered and discussed their experience with the different techniques. The speakers were invited to summarize their contributions together with their impressions on the present applicability of their approach. Several of the speakers followed this request which is summarized in this publication.

More books from Springer Netherlands

Cover of the book Tyssot De Patot and His Work 1655 – 1738 by
Cover of the book Value Functions for Environmental Management by
Cover of the book Foundations of Aversion Therapy by
Cover of the book Studies in Text Grammar by
Cover of the book The Practice of M-Mode and Two-Dimensional Echocardiography by
Cover of the book Small-Scale Steelmaking by
Cover of the book The Islets of Langerhans by
Cover of the book Ecology and Management of Coppice Woodlands by
Cover of the book Human Security by
Cover of the book Complexity in Chemistry and Beyond: Interplay Theory and Experiment by
Cover of the book Basic Notes in Psychiatry by
Cover of the book Functions of Natural Organic Matter in Changing Environment by
Cover of the book Climate Change: Significance for Agriculture and Forestry by
Cover of the book Animal Models in Cardiovascular Research by
Cover of the book In the Wrong Place - Alien Marine Crustaceans: Distribution, Biology and Impacts by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy